Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway

Clinical Pharmacology and Therapeutics

Volumn 70, Issue 2, 2001, Pages 183-188

  Loennechen, Thrina ^a,b   Utsi, Egil ^a,b   Hartz, Ingeborg ^a,b   Lysaa, Roy ^a,b   Kildalsen, Hanne ^a,b   Aarbakke, Jarle ^a,b  

^a Department of Pharmacology   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA; THIOPURINE METHYLTRANSFERASE;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE MUTATION; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; METHYLTRANSFERASES; MUTATION; NORWAY; PHENOTYPE; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 0034883283     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2001.117445     Document Type: Article

References (26)

1. Genetic polymorphism of thiopurine S-methyltransferase: Clinical importance and molecular mechanisms
2. Mercaptopurine pharmacogenetics: Monogenetic inheritance of erythrocyte thiopurine methyltransferase activity
3. Thiopurine methyltransferase activity in American white subjects
4. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia
5. Altered mercaptopurine metabolism, toxic effects and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymhocytic leukemia
6. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia
7. Thiopurine methyltransferase polymorphic tandem repeat: Genotype-phenotype correlation analysis
8. Pharmacogenomics: Translating functional genomics into rational therapeutics
9. A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase
10. Thiopurine S-methyltransfersase deficiency: Two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians
11. Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism
12. Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms
13. Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans
14. Detection of known mutations in the thiopurine S-methyltransferase gene by single strand conformation polymorphism analysis
15. Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance
16. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations
17. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans
18. Ethnic differences in thiopurine methyltransferase pharmacogenetics: Evidence for allele specificity in Caucasian and Kenyan individuals
19. Human thiopurine methyltransferase pharmacogenetics
20. Interethnic difference in thiopurine methyltransferase activity
21. The cardiovascular study of Finnmark 1974-1975
22. Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties
23. Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism
24. Thiopurine methyltransferase alleles in British and Ghanaian populations
25. Geographic patterns of mtDNA diversity in Europe
26. Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population